Rong-Kun Chang, PhD, is associate director at Supernus Pharmaceuticals.
Common Deficiencies in ANDAs for Dermatologic Drug Products
Companies may potentially accelerate the approval of generic drugs by avoiding deficiencies in ANDA submissions.